Form 4 · Filed Jun 15, 2026, 09:35 PM UTC
PBLS/Parabilis Medicines, Inc.
FITZGERALD EDWARD M — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | C | other | 5,539 | — | — | 5,539 |
| Jun 11, 2026 | C | other | 3,878 | — | — | 9,417 |
| Jun 11, 2026 | C | other | 5,271 | — | — | 14,688 |
| Jun 11, 2026 | C | other | 5,332 | — | — | 0 |
| Jun 11, 2026 | C | other | 3,666 | — | — | 0 |
| Jun 11, 2026 | C | other | 8,111 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-271344